Supplemental Table 1. 5-year CIN of LR, metastasis, DSD, and major poor outcomes for all immunosuppressed, SOT, and CLL by BWH stage

Name: Supplemental Table 1. 5-year CIN of LR, metastasis, DSD, and major poor outcomes for all immunosuppressed, SOT, and CLL by BWH stage
Creator: Kathryn Shahwan
Published: 2025-03-17T16:21:07.853Z
Keywords: Squamous Cell Carcinoma

Shahwan, Kathryn

doi:10.17632/f4ypn635rs.1

Supplemental Table 1. 5-year CIN of LR, metastasis, DSD, and major poor outcomes for all immunosuppressed, SOT, and CLL by BWH stage

Published: 17 March 2025| Version 1 | DOI: 10.17632/f4ypn635rs.1

Contributor:

Kathryn Shahwan

Description

Supplemental Table 1. 5-year cumulative incidence (CIN) of local recurrence (LR), metastasis, disease-specific death (DSD), and major poor outcomes (MPO) for all immunosuppressed (IS) patients, solid organ transplant (SOT) recipients, and chronic lymphocytic leukemia (CLL) patients by Brigham and Women’s Hospital (BWH) stage, with 95% confidence intervals (CI)

Supplemental Table 1. 5-year CIN of LR, metastasis, DSD, and major poor outcomes for all immunosuppressed, SOT, and CLL by BWH stage

Description

Files

Categories

Licence